课题基金 / 基金详情

Regulation of Anti-Microbial Macrophage Response to Pulmonary Infections

Regulation of Anti-Microbial Macrophage Response to Pulmonary Infections
肺部感染的抗微生物巨噬细胞反应的调节
批准号：
313062
负责人：
Divangahi Maziar
金额：
$94.21万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-09-01 至 2019-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=313062&lang=en
关键词：
Adaptive Immunity Cell Death Program Eicosanoids Immunity To Pulmonary Infections Influenza Virus Innate Immunity Macrophage Biology Mouse Models Mycobacterium Tuberculosis Pulmonary Immunology

项目摘要

项目成果

Divangahi Maziar的其他基金

相似基金

相关文献

中文摘要
翻译
<html> <body> <p> <strong>在</strong>全球范围内，呼吸道感染每年造成400多万人死亡，其中流感和结核病（TB）尤其是死亡和发病的主要原因。虽然免疫反应是必要的，
英文摘要
<html> <body> <p> <strong>Summary:</strong> Globally, respiratory infections cause more than 4 million deaths per year, with influenza and tuberculosis (TB) in particular being major causes of mortality and morbidity. Although an immune response is req
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a novel vaccine against COVID-19
Targeting the eicosanoid/macrophage axis to enhance host defense against influenza virus infection
Reprogramming HSCs to generate protective trained immunity against TB
Monocyte/Macrophage Biology Symposium: Cracking the Macrophage Code in Host Defense and Tolerance
海外基金